😗 year 2017.
Certain treatments for patients suffering from chronic diseases, such as inflammatory bowel diseases, require multiple intravenous or subcutaneous injections of specific drugs. Because of the pain and anxiety associated with needles, some patients stop adhering to these treatments.
MIT spinout Portal Instruments has now landed a commercialization deal for a smart, needle-free injection device that could reduce the pain and anxiety associated with needle injections, shorten administration time, and improve patient adherence.
Based on years of MIT research, the startup developed a jet-injection device that delivers a rapid, high-pressure stream of medicine, as thin as a strand of hair, through the skin in adjustable dosages, causing little to no pain. A connected app tracks each dose and the medicine’s effects, and uploads that information to the cloud, for patients and doctors. The device would be sold as a drug-device combination product to medical professionals and provided to patients with a prescription.
Comments are closed.